Standing up in public for a broader conception of value in healthcare.

9-16 of 74 News

press 6/13/17

IVI Highlighted in Article on Value Assessment in Oncology Treatments The IVI was recently highlighted in a article focused on value assessment in oncology treatments, emphasizing the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. READ MORE

viewpoint 6/08/17

Jena and Goldman Discuss the Challenges of Value-Based Pricing in STAT News In a new commentary for STAT News, Anupam Jena (part of IVI's scientific advisory group) and Dana Goldman discuss the advantages of value-based pricing, pointing out several of the key challenges that complicate the application of health technology assessments. READ MORE

viewpoint 6/02/17

On the Health Affairs Blog: Light Addresses the Pharma "Free Rider Myth” (in Response To Yu, Helms, and Bach) Donald Light submits a response to Yu, Helms and Bach's recent Health Affairs blog post on the subject of drug pricing. Light argues that, because the commentary by Yu, Helms, and Bach focuses on the excess of US drug pricing over prices in other developed countries, the authors risk promoting the so-called "foreign free-rider myth," relying on a misperception that the US is paying more than their fare share of drug development costs. READ MORE

viewpoint 6/02/17

On the Health Affairs Blog: Grabowski and Manning Respond To A Recent Post by Yu, Helms, and Bach Henry Grabowski and Richard Manning offer a rebuttal to a recent Health Affairs blog post by authors Yu, Helms, and Bach on the subject of drug pricing, arguing the authors’ premise is flawed and suffers from numerous biases and related methodological issues. READ MORE

viewpoint 6/01/17

On the Health Affairs Blog: Carrier and Shadowen Propose Fixes for Pharma "Product Hopping" Michael Carrier and Steve Shadower present the issue of "product hopping," in which pharma manufacturers can delay the generic introduction of a drug through reformulation. In addition to examining the issue, Carrier and Shadowen propose some criteria for the development of a new framework to address abuses in this practice. READ MORE

viewpoint 5/26/17

On the Health Affairs Blog: Manolis, Good and Shrank Address Abuse-Deterrent Opioids Chronis Manolis, C Bernie Good and William Shrank discuss current approaches to curb opioid abuse, including the proposal to mandate coverage of abuse-deterrent opioids. READ MORE

viewpoint 5/23/17

On the Health Affairs Blog: What Matters Most To Patients Josh Seidman, Margaret Anderson, Domitilla Masi, Melea Atkins and Maureen Japha provide an overview of the Avalere-FasterCures Patient-Perspective Value Framework. READ MORE

event 5/23/17

Baumgardner Participates in Becker Friedman Institute's Health Care Reform Panel On May 22nd, James Baumgardner, who provides legislative policy expertise as a part of IVI's Scientific Advisory Group, was an invited panelist for a forum at The University of Chicago's Becker Friedman Institute. READ MORE